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Chronic oxidative stress has been implicated in both the
initiation and progression of pathophysiological phenomena
in the trabecular meshwork (TM) in glaucoma [1-3]. Primary
open-angle  glaucoma  (POAG)  has  been  shown  to  be
associated with a signiﬁcant increase in the accumulation of
the primary and secondary end products of lipid peroxidation
in lipid extracts from TM, aqueous humor, and Schlemm’s
canal (SC) [3,4]. Similarly, signiﬁcantly higher levels of the
product  of  DNA  oxidation  8-oxo-2,7-dihydro-20-
deoxyguanosine have been observed in the TM of glaucoma
patients  compared  with  age-matched  and  sex-matched
controls,  and  the  levels  of  DNA  damage  were  correlated
signiﬁcantly with elevation of intra-ocular pressure and visual
field defects [1,2,5,6]. Furthermore, reactive oxygen species-
mediated  damage  to  the  TM  has  been  shown  to  induce
alterations that result in increased aqueous humor outflow
resistance [1,7].
Oxidative damage can lead to outflow tissue dysfunction
through apoptotic cell loss [8] by inducing certain phenotypic
alterations,  including  those  associated  with  stress-induced
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senescence.  One  such  phenotypic  alteration  that  has  been
proposed to explain how oxidative damage might contribute
to the malfunction of the TM is the induced upregulation of
extracellular matrix (ECM) genes [9]. Such upregulation of
ECM-related  genes  could  potentially  contribute  to  the
accumulation  of  ECM  components  in  the  sheath-derived
plaques (SD-plaques) that have been shown to increase in the
TM with aging and in POAG [10]. However, the specific
molecular mechanisms involved in the alterations in ECM
induced by oxidative stress in TM cells are not completely
understood.
MicroRNAs  (miRNAs)  are  an  abundant  class  of
noncoding small (~22 nucleotides) RNAs that modulate gene
expression at the post-transcriptional level and participate in
the  regulation  of  many  cellular  functions  [11-13].
Specifically,  miR-29b  has  been  demonstrated  to  regulate
multiple genes coding for ECM proteins, including multiple
collagens, fibrillins, and elastin. MiR-29 is a positive regulator
of osteoblast differentiation and controls the expression of
collagens in differentiated osteoblasts [14]. This miRNA has
also  been  found  to  be  downregulated  in  various  cancers
[15-18] and targets extracellular matrix collagens in lung and
nasopharyngeal  cancer  cells  [18].  MiR-29b  is  also
downregulated in myocardial infarct, and its downregulation
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Purpose: To investigate the role of miR-29b on the changes in expression of genes involved in the synthesis and deposition
of extracellular matrix (ECM) induced by chronic oxidative stress in human trabecular meshwork cells (HTM).
Methods: Changes in gene expression induced by miR-29b in HTM cells were evaluated by gene array analysis using
Affymetrix U133A2 arrays and confirmed by quantitative–PCR. Pathway analysis was conducted using Metacore.
Targeting of miR-29b to the 3’-untranslated region of three novel putative targets was evaluated using the Psicheck
luciferase system. Chronic oxidative stress was induced by incubation at 40% oxygen for 4–5 days, using cultures
incubated at 5% oxygen as controls. Changes in expression in microRNA or gene expression were analyzed by Q-PCR.
Cell viability was measured by lactate dehydrogenase release.
Results: Transfection of HTM cells with miR-29b mimic resulted in downregulation of multiple ECM components,
including collagens (COL1A1, COL1A2, COL4A1, COL5A1, COL5A2, COL3A1) LAMC1, and FBN as well as several
genes  involved  in  ECM  deposition  and  remodeling,  such  as  SPARC/osteonectin.  Three  additional  genes,  BMP1,
ADAM12, and NKIRAS2, were identified as direct targets of miR-29b. Chronic oxidative stress induced a significant
downregulation of miR-29b in two HTM cell lines that was associated with increased expression of several ECM genes
known to be regulated by miR-29b. The increase in expression of these genes was inhibited by transfection with miR-29b
mimic. MiR-29b increased cell viability under both chronic oxidative stress and physiologic oxygen concentrations.
Conclusions: MiR-29b negatively regulates the expression of multiple genes involved in the synthesis and deposition of
ECM in trabecular meshwork (TM) cells. Downregulation of miR-29b might contribute to increased expression of several
ECM genes under chronic oxidative stress conditions. The balance between the activation of ECM production induced
by oxidative stress and the protective effects of miR-29b could be a relevant factor in understanding how oxidative damage
may lead to increased deposition of ECM in the TM and contribute to the elevation of intra-ocular pressure in glaucoma.has been shown to contribute to fibrosis in the heart [19]. Thus,
miR-29 would be predicted to contribute to the regulation of
ECM dynamics in the TM. However, the roles of this miRNA
in the TM and the potential involvement on the alterations in
ECM synthesis induced by oxidative stress in TM cells have
not been investigated.
To gain more insight into the potential role of miR-29b
in the TM, we investigated the effects of chronic oxidative
stress on the expression of miR-29b, analyzed the changes in
gene expression mediated by miR-29b, and evaluated whether
alterations  in  miR-29b  expression  might  alter  the  effects
induced by chronic oxidative stress in human TM (HTM)
cells.
METHODS
Cell  cultures  and  oxidative  stress  conditions:  HTM  cell
cultures were generated from cadaver eyes, with no history of
eye disease, within 48 h post mortem, as previously reported
[20]. All procedures involving human tissue were conducted
in accordance with the tenets of the Declaration of Helsinski.
Cell cultures were maintained at 37 oC in 5% CO2 in media
(low glucose Dulbecco’s Modified Eagle Medium with L-
glutamine, 110 mg/ml sodium pyruvate, 10% fetal bovine
serum,  100  µM  nonessential  amino  acids,  100  units/ml
penicillin,100 µg/ml streptomycin sulfate, and 0.25 µg/ml
amphotericin  B).  All  the  reagents  were  obtained  from
Invitrogen Corporation (Carlsbad, CA). Oxidative stress was
induced by incubation at 40% oxygen 5% CO2 for 4–5 days.
Cells  incubated  at  40%  oxygen  were  compared  to  cells
incubated  at  an  oxygen  concentration  close  to  the
physiological concentration reported in the aqueous humor
(oxygen partial pressure PO2 5%) [21].
Transfections: HTM cells were plated 24 h before transfection
with  hsa-miR-29b  mimic  or  control  mimic  (scramble;
20-40pmolar [Dharmacon, Chicago, IL] with Lipofectamine
2000 [Invitrogen] or amaxa nucleofactor kit [Lonza, Basel,
Switzerland])  following  the  manufacturer’s  instructions.
Briefly, for nucleofection, cells were transfected at density of
4×106 using an endothelial nucleofactor Kit and the program
T23 in the Nucleofector, following the basic protocol for
primary mammalian endothelial cells and 20 picomolar of
miRNAs (Amaxa, scientific-support.US@amaxa.com).  For
lipofectamine transfections, cells were seeded at 2-3×105 cells
in 12 well plates or 5-6×105 cells in 6 well plates using 40
picomolar miRNAs and 1 or 2 µl of lipofectamine (for 12 and
6 well plates, respectively) and OPTI-MEM I  (Invitrogen).
Cotransfections of 293A cells with luciferase 3’untranslated
region (UTR) constructs (0.3 µg), miR-29b mimic, or control
mimic  (20  pmolar)  were  accomplished  using  Effectene
(Qiagen, Valencia, CA).
Gene  microarray  analysis:  Gene  array  analysis  was
conducted  in  three  independent  sets  of  transfections  with
TABLE 1. PRIMERS USED FOR AMPLIFICATION OF THE 3’ UNTRANSLATED REGIONS OF BMP1, ADAM12, AND NKIRAS2.
Gene symbol Forward 5'-3' Reverse 5'-3'
BMP1 GGCTCGAGGGCCTGCCAGGCCTCCCG GGGCGGCCGCGCAAGAGAAAGGAGCAGGAC
ADAM12 GGCTCGAGGTGAAGACAGAAGTTTGCAC GGGCGGCCGCTCATATCCTCTTATAATTGG
NKIRAS2 GGGCTCGAGGCTGCCGTTCCTCTTTCACG GGGGCGGCCGCGTGTCCAACCAATGCATCAA
TABLE 2. PRIMERS USED FOR Q-PCR AMPLIFICATION.
Gene symbol FORWARD 5'-3' REVERSE 5'-3'
STC1 TCAGAGACAGCCTGATGGAG CCTCACCTCGGAGGTTCCTG
STC2 TCTGCACCTCGGCCATCCAG TCAGAATACTCAGACTGTTC
COL4A1 CCTGGCTTGAAAAACAGCTC AGGCCTAGTGGTCCGAATCT
CRABP2 GTGATGCTGAGGAAGATTGC CCACAGTCTGCTCCTCAAAC
TIMP3 TGCAGCTGGTACCGAGGATG CAGGCACTAATTTCATTGTC
LOXL2 TACCTGGAGGACCGGCCCATG AGGTCATAGTGGGTGAACAC
COL1A1 AGCCAGCAGATCGAGAACAT TCTTGTCCTTGGGGTTCTTG
COL1A2 TGCAAGAACAGCATTGCATAC GGCAGGCGAGATGGCTTATTTGTT
COL3A1 CCATGAATGGTGGTTTTCAG GTGTTTAGTGCAACCATC
COL5A1 GGCTGTGCTACCAAGAAAGG GAGGTCACGAGGTTGCTCT
COL5A2 TGATCCTGAGACTCTTGAAG GGTGGTCATTGTCATTGGTC
LAMC1-1 AATGAAGCCAAGAAGCAGGA ATGGACAGCAGCAGAGGAGT
SPARC CCGGGACTTCGAGAAGAACT CTCATCCAGGGCAATGTACT
FBN1 CTGCAAGAGGATGGAAGGAG GGTAAATCCGGGAGGACATT
BMP1 GTGTGGCCCGATGGGGTCAT CCCGCAAGGTCGATAGGTGAA
ADAM12 ATGTGGAAAAATCCAGTGTC GCAAGCACAAGCCCTGGGTC
NKIRAS2 CAGGAGCAGCGGCGTGTAGA GCCATCCAAGGAGCCGCTGC
ACTB CCTCGCCTTTGCCGATCCG GCCGGAGCCGTTGTCGACG
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2489either miR-29b mimic or mimic control of the same HTM cell
line. Total RNA was extracted three days post transfection
using  RNeasy  kit  (Qiagen),  amplified  (one  round
amplification) using one cycle target labeling and control
reagents (Affymetrix, Santa Clara, CA), and hybridized to
human  genome  U133A2  arrays  (Affymetrix)  at  the  Duke
University Microarray facility. Raw data were normalized and
analyzed  using  GeneSpring  7.3  (Silicon  Genetics,  Santa
Clara, CA). Genes were filtered to their intensities in the
control  channel.  Pre-mixed  polyadenylated  prokaryotic
sequences from the One cycle target labeling and control
reagents  kit  (Affymetrix)  were  spiked  directly  into  the
samples before target labeling and used as controls. Raw data
values below 100 were considered as unreliable. Intensity-
dependent normalization was performed per spot and per chip
(LOWESS normalization). ANOVA test was performed (p-
values  ≤0.05  were  considered  significant)  for  genes
differentially expressed, using the Benjamin and Hochberg
False Discovery Rate correction test. The list of genes were
compared to three databases that predict targets for miRNAs:
Microcosm,  TargetScan,  and  PicTar-Vert.  To  study  the
potential biological significance of the changes observed in
the arrays, we performed network analysis of differentially
expressed genes, using Metacore pathway analysis (GeneGo,
St. Joseph, MI).
Analysis of miR-29b interaction with 3’ untranslated regions:
The  entire  3’UTRs  from  bone  morphogenic  protein  1
(BMP1),  ADAM  metallopeptidase  domain  12  (ADAM12),
and  NFKB  inhibitor-interacting  Ras-like  protein  2
(NKIRAS2) were amplified using primers in Table 1, with
carried XhoI and NotI restriction sites in the forward or the
reverse position. PCR amplifications from 3’UTRs and the
complementary sequences were confirmed by sequencing and
cloned  into  XhoI  and  NotI  sites  downstream  of  Renilla
luciferase in the psiCheck2 vector (Promega, Madison, WI).
For analysis of luciferase activity, 293A cells were seeded in
12-well culture dishes 24 h before transfection and transfected
with psicheck 3’UTR, or the complementary sequence from
BMP1, ADAM12, or NKIRAS2 (300 ng), and miRNAs for
29b mimic or control mimic. Luciferase was measured using
the Dual Luciferase Kit (Promega, Madison, WI) following
manufacturer’s  instructions  and  read  in  a  TD-20/20
luminometer (Turner Designs, Sunnyvale, CA). In this assay,
the  activities  of  Photinus  pyralis  and  Renilla  reniformis
luciferases are measured sequentially from a single sample.
The firefly reporter is measured first by adding Luciferase
Assay  Reagent  II  to  generate  a  luminescent  signal.  After
quantifying  the  firefly  luminescence,  this  reaction  is
quenched,  and  the  Renilla  luciferase  reaction  is
simultaneously initiated by adding Stop & Glo® Reagent to
the same tube.
RNA isolation and Quantitative PCR: Total RNA was isolated
using  an  RNeasy  kit  (Qiagen  Inc.)  or  Trizol  (Invitrogen)
extraction, according to the manufacturer’s instructions. RNA
yields  were  measured  using  RiboGreen  fluorescent  dye
(Invitrogen). First-strand cDNA was synthesized from total
RNA  (1  µg)  by  reverse  transcription  using  oligodT  and
Superscript II reverse transcriptase (Invitrogen), according to
the  manufacturer’s  instructions.  Quantitative  (Q)-PCR
reactions were performed in a 20-µl mixture containing 1 µl
of the cDNA preparation, 1X iQ SYBR Green Supermix (Bio-
Rad, Hercules, CA), using the following PCR parameters: 95
°C for 5 min followed by 50 cycles of 95 °C for 15 s, 65 °C for
15 s and 72  °C for 15 s. β-Actin was used as an internal
standard of mRNA expression. The absence of nonspecific
products was confirmed by both the analysis of the melt curves
and by electrophoresis in 3% Super AcrylAgarose gels (DNA
technology, Risskov, Denmark). The primers used for Q-PCR
amplification  are  shown  in  Table  2.  MicroRNAS  were
extracted  using  RT2  qPCR-Grade  miRNA  isolation  kit
(SABiosciences, Frederick, MD) from total RNA extracted
with Trizol. miRNAs cDNA (25 ng) were amplified using
TaqMan  microRNA  reverse  transcription  Kit  (Applied
Biosystems,  Foster  City,  CA)  and  specific  primers  for
miR-29b and U6B (Applied Biosystems), as a standard. Q-
PCR products were amplified using TaqMan® Universal PCR
Master Mix (Applied Biosystems), following manufacturer’s
instructions. Briefly, TaqMan quantification is a two step
process, in the reverse transcription step cDNA was reverse
transcribed from RNA enriched with miRNAs using miR29b
and U6B specific primers. PCR products were amplified from
these cDNAs using 29b and U6b probes and the recommended
PCR parameters: 95 °C for 10 min followed by 40 cycles of
95 °C for 15 s and 60 °C for 1 min. During PCR, the probe
anneals specifically to a complementary sequence between
the forward and reverse primer sites, when the probe is intact
the proximity of the reporter dye to the quencher dye results
in suppression of reporter fluorescence. The DNA polymerase
cleaves  only  probes  that  are  hybridized  to  the  target,  the
cleavage separate the reporter from the quencher and this
separation results in increased fluorescence by the reporter.
The fluorescence threshold value (Ct) was calculated using the
iCycle system software (Bio-Rad). The results were expressed
as  mean  value±  SE  (standard  error)  in  three  independent
experiments.
Cell viability assay: To evaluate changes in cell viability
induced  by  miR-29b,  cells  were  transfected  with  control
mimic or miR-29b mimic. Cell viability was assayed after 5
days  at  40%  and  5%  oxygen,  by  measuring  the  lactate
dehydrogenase released to the culture media as a result of
plasma  membrane  damage  using  the  Cito  Tox  96®  Non-
Radioactive  Cytotoxicity  assay  (Promega)  following  the
manufacturers instructions. Briefly, LDH was measured in
culture supernatants and in cell lysates from each well, in a
30-min  coupled  enzymatic  reaction,  which  results  in  the
conversion of a tetrazolium salt (INT) into a red formazan
product. The amount of color formed is proportional to the
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2490TABLE 3. GENES UP-OR DOWN-REGULATED AFTER TRANSFECTION WITH HSA-MIR-29B IN HTM CELLS.
Genebank Symbol p value Fold Microcosm Targetscan Pictar
Selected genes up or down regulated by 2 fold or greater
Down-regulated
AF130082 COL3A1 0.0062 -4.310 * * *
AI983428 COL5A1 0.0065 -3.876      
N30339 COL5A1 0.0036 -3.597      
NM_000090 COL3A1 0.0068 -3.571 * * *
BC000658 STC2 0.0284 -3.356      
K01228 COL1A1 0.0154 -3.3   * *
Y15916 COL1A1 0.0036 -3.268   * *
AI300520 STC1 0.0177 -3.236      
AL575735 COL5A2 0.0036 -3.096   * *
AI743621 COL1A1 0.0188 -3.086   * *
W46291 ADAM12 0.0121 -3.077   *  
BE251211 LOXL2 0.0177 -3.03      
U05598 AKR1C2 0.0008 -2.959      
M33376 AKR1C2 0.0068 -2.915      
AW188198 TNFAIP6 0.0447 -2.817      
U46768 STC1 0.0275 -2.817      
AU144167 COL3A1 0.0068 -2.786 * * *
AL575735 COL5A2 0.0093 -2.695   * *
AF117949 LOXL2 0.0163 -2.475      
NM_024089 KDELC1 0.0395 -2.463 * * *
NM_006186 NR4A2 0.0144 -2.445      
NM_007115 TNFAIP6 0.0144 -2.398      
NM_001353 AKR1C1 0.0079 -2.398      
NM_003155 STC1 0.0062 -2.375      
BE962749 PPIC 0.0036 -2.347 * * *
NM_003474 ADAM12 0.0342 -2.32 *  
AF118094 TAF11 0.0163 -2.232 *    
AL050136 TMF1 0.0072 -2.222      
S68290 AKR1C1 0.0065 -2.222      
AA530892 DUSP1 0.0236 -2.155      
AI922605 COL4A1 0.0157 -2.155 * * *
NM_004353 SERPINH1 0.0068 -2.146      
BC001131 HIST1H2BG 0.0263 -2.137      
NM_005689 ABCB6 0.0121 -2.123 * * *
NM_000943 PPIC 0.0275 -2.114 * * *
AL567376 LYPD1 0.0132 -2.058      
NM_000089 COL1A2 0.0181 -2.045 * * *
NM_006455 SC65 0.043 -2.004      
BC000055 FSTL1 0.0067 -2   * *
Up-regulated
NM_022817 PER2 0.0144 2.01      
NM_021245 MYOZ1 0.0144 2.354      
NM_006895 HNMT 0.0068 2.442      
NM_001878 CRABP2 0.0163 2.607      
Selected genes up or down regulated between 1.5 and 1.9 fold
Down-regulated
NM_004995 MMP14 0.0154 -1.953      
Z48481 MMP14 0.0275 -1.88      
NM_002293 LAMC1 0.0143 -1.689 * * *
BE222709 MFAP3 0.0063 -1.543 * * *
AL575922 SPARC 0.0062 -1.529   * *
NM_000138 FBN1 0.0128 -1.529 * * *
Up-regulated
NM_002575 SERPINB2 0.05 1.9      
NM_000362 TIMP3 0.0461 1.83      
NM_002160 TNC 0.0157 1.74      
NM_021111 RECK 0.0068 1.503      
This table shows genes that significantly change expression after transfection with miR-29b compared to controls by gene array
analysis. The asterisks indicates the miRNA databases that predicts these genes as putative targets for miR29b.
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2491number of lysed cells. LDH in the supernatant was corrected
for the total LDH (Supernatant/Supernatant + cell lysis). For
each sample the quantification was performed in duplicate.
The  results  were  expressed  as  mean  value±SE  in  three
independent experiments.
RESULTS
Changes in gene expression induced by miR-29b in human
trabecular meshwork cells: Differences in gene expression
induced by miR-29b were evaluated by gene array analysis
using Affymetrix U133A2 chips. HTM cells were transfected
with miR-29b mimic and gene expression was compared to
that in cell cultures transfected with a control mimic. One
hundred  sixteen  genes  represented  by  181  probes  were
significantly  (p≤0.05)  upregulated  or  downregulated  more
than 1.5-fold. Thirty-one percent of these transcripts were
predicted in at least one of the three miRNA databases as
putative targets for miR-29b. MiR-29b downregulated several
ECM structural proteins, as collagens (COL5A2, COL5A1,
COL4A1,  COL3A1,  COL1A1,  and  COL1A2)  laminin  C,
fibrillin  1,  and  microfibrillar-associated  protein  3;  and
extracellular  matrix  regulators,  such  as  MMP14,  LOXL2,
SERPINH1, SPARC, TNFAIP6, and ADAM 12. Other matrix
TABLE 4. VALIDATION OF GENE EXPRESSION CHANGES AFTER TRANSFECTION WITH HSA-MIR29B.
Gene                              Arrays     HTM -1     HTM-2     HTM-3
Fold p-value Fold p-value Fold p-value Fold p-value
COL1A2 -2.0450 0.0181 -1.5874 0.0086 -2.2974 0.0006 -2.1189 0.0104
COL5A2 -3.0960 0.0036 -2.7007 0.0013 -2.0946 0.0486 -1.9543 0.0410
COL5A1 -3.8760 0.0065 -1.8234 0.0095 -2.6390 0.0138 -2.4340 0.0017
COL3A1 -4.3100 0.0062 -3.0314 0.0167 -2.9622 0.0002 -2.1685 0.0088
COL1A1 -3.3003 0.0154 -1.7818 0.0019 -2.8945 0.0000 -2.0467 0.0416
COL4A1 -2.1552 0.0157 -2.5247 0.0078 -2.3217 0.0091 -1.4473 0.0042
STC1 -3.2362 0.0177 -1.4641 0.0132 1.0353 0.3437 -1.6818 0.0349
LOXL2 -2.4752 0.0163 -1.8234 0.0718 -1.7818 0.0044 -2.1936 0.0493
STC2 -3.3557 0.0284 -2.2191 0.0221 -1.4811 0.0029 -1.8234 0.0243
FBN1 -1.5291 0.0128 -1.6434 0.0015 -2.1435 0.0053 -1.6434 0.0500
LAMC1 -1.6892 0.0143 -1.7211 0.0184 -2.2449 0.0072 -1.9770 0.0136
SPARC -1.5291 0.0062 -1.4641 0.0464 -2.5787 0.0066 -1.4983 0.0219
CRABP2 2.6070 0.0163 1.8446 0.0222 2.8284 0.0109 2.0467 0.0251
TIMP3 1.8300 0.0461 2.7638 0.0258 -1.3044 0.3918 1.9000 0.0311
Fold changes refers to the ratio of the expression values of the cells transfected with miR-29b over the cells transfected with
scramble. P-values for the Q-PCR refer to the t-test between normalized CT values in cells transfected with miR-29b versus cells
transfected with scramble.
Figure 1. Pathway analysis of changes
in gene expression induced by miR-29b.
Genes showing changes in expression
higher  than  1.5  fold  (p<0.05)  after
transfection with miR-29b mimic using
Affymetrix  U133A2  arrays  were
analyzed  with  Metacore  pathway
analysis. The canonical pathway maps
used in this analysis represent a set of
650  signaling  and  metabolic  maps
generated  from  the  GeneGo  database
(GeneGo, St. Joseph, MI). The figure
shows the 10 canonical pathways most
significantly  affected  by  transfection
with  miR-29b  mimic  compared  to
controls. In the figure, ECM represents
extracellular  matrix;  TGF  represents
transforming  growth  factor;  EGFR
represents epidermal growth factor; and
GPCRs  represents  G  protein-coupled
receptors.
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symbolregulators, such as plasminogen activator inhibitor 2, RECK,
and TIMP3, showed upregulation. Table 3 shows transcripts
upregulated or downregulated by more than twofold and some
selected  genes  related  to  ECM  that  were  significantly
downregulated or upregulated between 1.5- and 1.9-fold.
To  validate  Affymetrix  microarray  data,  changes  in
expression of 14 genes were analyzed by Q-PCR in three
independent HTM cell lines different from the one used for
array hybridization (Table 4).
Functional  network  analysis  of  gene  expression  changes
induced by miR-29b: In order to identify the pathways and
regulatory elements more likely associated with the changes
in gene expression induced by miR-29b, genes significantly
(p<0.5) upregulated or downregulated by 1.5-fold in the array
analysis were further analyzed using MetaCore algorithms.
The three canonical pathways most significantly affected by
miR-29b  are  represented  in  Figure  1  and  include  cell
adhesion–ECM  remodeling  (p=1.5  E-107);  cytoskeleton
remodeling (p=2 E-105), and cell adhesion–integrin-mediated
cell adhesion and migration (p=4 E-105; Figure 1). Analysis
of  transcription  factor  regulation  identified  SP1  as  the
transcription  factor  most  significantly  (p=4.82  E-106)
involved in the regulation of genes affected by miR-29b with
46 nodes (Figure 2).
Targeting  of  the  3’  untranslated  regions  of  BMP1,
ADAM12, and NKIRAS2 mRNA by miR-29b: Computational
predictions  indicate  that  miR-29b  shares  complementarity
with sequences in the 3’UTR of three genes found to be
downregulated  by  miR-29b  according  to  the  gene  array
analysis: BMP1, ADAM12, and NKIRAS2 (Figure 3A). We
investigated whether miR-29b could interact with the 3’UTRs
of these genes by using the psiCheck2 luciferase assay system.
MiR-29b mimic significantly reduced luciferase expression
in cells cotransfected with the 3’UTR of BMP1, ADAM12, or
NKIRAS2  compared  to  mimic  control  (scramble).  The
decrease in luciferase activity was completely or significantly
prevented when the 3’UTR complementary sequences were
used (Figure 3B). Downregulation of these gene transcripts
by miR-29b was confirmed by Q-PCR in three HTM cells
lines (Figure 3C).
Effects  of  chronic  oxidative  stress  on  the  expression  of
miR-29b.:  Changes  in  expression  of  miR-29b  induced  by
chronic oxidative stress were analyzed by Q-PCR in three
independent HTM lines after 4 days at 40% oxygen compared
to  parallel  cultures  incubated  at  5%  oxygen.  In  these
conditions miR-29b decreased significantly between 2- and
2.5-fold in two of the three cell lines analyzed and showed no
significant change in a third line (Figure 4).
Role of miR-29b on changes in expression of extracellular
matrix  genes  induced  by  chronic  oxidative  stress.:  To
investigate whether the downregulation of miR-29b observed
in two cell lines could mediate alterations in gene expression
induced by chronic oxidative stress, the effects of incubation
at 40% oxygen on the expression of six genes known to be
regulated  by  miR-29b  (COL1A2,  COL5A1,  COL3A1,
COL1A1, LAMC, and SPARC) were analyzed in the same
three HTM cell lines used in the previous experiment. The
experiments were conducted in cells transfected with either
control mimic or miR-29b mimic. Although there was a high
level of variability in the effects of chronic oxidative stress on
the expression of the selected genes, the two cell lines where
miR-29b  had  been  found  to  be  downregulated  more  than
twofold under oxidative stress conditions showed a significant
increase  in  the  expression  of  several  genes  regulated  by
miR-29b. In contrast, incubation at 40% oxygen had little
effect on the expression of these genes in the cell line where
miR-29b had not been found to be altered by chronic oxidative
stress. In all cell lines, transfection with miR-29b mimic led
to  either  a  significant  downregulation  or  decrease  in  the
upregulation mediated by chronic oxidative stress of all genes
analyzed compared to cultures transfected with control mimic
(Figure 5).
Figure  2.  Genes  known  to  be  regulated  by  SP1  that  showed
significant differences in expression after transfection with miR-29b
mimic by array analysis. Metacore analysis of the genes showing
significant  differences  (p<0.5)  in  expression  in  the  Affymetrix
U133A2  arrays  identified  SP1  as  the  transcription  factor  more
significantly (p= 4.82 E-106) associated with these gene expression
changes. Green lines represent upregulation by SP1, red lines a
downregulation,  and  gray  lines  an  unspecified  effect.  Genes
significantly upregulated in gene array analysis of cells transfected
with  miR-29b  are  labeled  with  red  dots.  Genes  significantly
downregulated  by  miR-29b  are  labeled  with  blue  dots.
Inconsistencies between the array data and the effects predicted by
Metacore based on the literature are labeled with a star.
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2493Effects of miR-29b on cytotoxicity: HTM cells transfected
with control mimic or miR-29b mimic were subjected to 40%
or 5% oxygen and analyzed for cytotoxicity after 5 days. Cells
transfected  with  miR-29b  mimic  showed  a  significant
decrease  in  cytotoxicity  compared  to  the  control  in  both
oxygen concentrations (5 and 40%) except for HTM cell line
3  at  40%  O2,  which  showed  a  nonsignificant  decrease  in
cytotoxicity (Figure 6).
Figure  3.  Targeting  of  the  3’-unstranslated  regions  of  BMP1,
ADAM12,  and  NKIRAS2  by  miR-29b.  A:  Predicted  interactions
between  miR-29b  with  the  3’-unstranslated  region  (3’  UTR)  of
BMP1 (PicTar-Vert), ADAM12 (TargetScan), and NKRAS2 (PicTar-
Vert). Seed regions are highlighted in bold. B: Luciferase activity in
293 cells cotransfected with psicheck vectors containing the 3’UTR
or  complementary  sequence  (R)  from  BMP1,  ADAM12,  or
NKIRAS2 and miR-29b or scramble. C: Changes in expression of
ADAM12, BMP1, and NKIRAS2 were measured by Q-PCR after
transfection with miR-29b mimic or scramble. The figures represent
the logarithm of the fold change in gene expression compared to cells
transfected with scramble in three different cells lines. Bars represent
standard  error  from  three  different  experiments;  one  asterisk
indicates a p≤0.05, and two asterisks indicate a p≤0.01.
DISCUSSION
Our results showed that miR-29b negatively regulates the
expression in HTM cells of multiple genes involved in ECM
synthesis, deposition, and remodeling. In addition, incubation
under  chronic  oxidative  stress  conditions  (4  days,  40%
oxygen) resulted in a significant downregulation of miR-29b
in  two  of  the  three  HTM  cell  lines  analyzed.  This
downregulation  was  associated  with  an  increase  in  the
expression of several ECM genes known to be regulated by
miR-29b.  The  upregulation  of  these  genes  by  chronic
oxidative stress was inhibited by transfection with miR-29b
mimic.
The  multiple  effects  on  the  expression  of  ECM
components observed in HTM cells were consistent with the
antifibrotic activity previously reported for miR-29b in the
Figure 4. Changes in miR-29b induced by chronic oxidative stress.
To investigate if miR-29b changes with chronic oxidative stress,
three human trabecular meshwork (HTM) cell lines were incubated
during 4 days at 40% oxygen, and the changes in the expression of
miR-29b  were  quantified  by  quantitative–PCR  (Q-PCR)  and
compared  to  nonstressed  controls  incubated  at  5%  oxygen.  The
figures represent the logarithm of the fold change in gene expression
between cells incubated at 40% oxygen compared to controls. Bars
represent standard error from three different measurements. One
asterisk means p≤0.05.
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2494heart  [19].  These  effects  include  the  downregulation  of
validated targets, such as COL1A1,COL1A2,COL3A1,FBN1,
and SPARC [19,22].
MiR-29b also downregulated numerous genes that have
not been confirmed as direct targets of this miRNA. Some of
these genes contained sequences in their 3’UTRs that are
predicted to anneal to miR-29b and may potentially interact
with miR-29b. Among these genes, BMP1, ADAM12, and
NKIRAS2 were confirmed by luciferase analysis to contain
3’UTRs that can be directly targeted by miR-29b and should
be considered targets of this miRNA. However, many of the
gene expression changes induced by miR-29b affected genes
that lack any predicted targeting sequence for miR-29b and
appear to be secondary targets. Pathway analysis indicated
that a number of these genes are positively regulated by the
transcription  factor  SP1,  which  is  a  validated  target  of
miR-29b [23], suggesting that inhibition of SP1 by miR-29
may be an important factor in the overall effects on gene
expression mediated by miR-29b.
Exposure to chronic oxidative stress conditions for 4 days
resulted in a significant decrease in expression of miR-29b in
two  (HTM1  and  HTM2)  of  the  three  cell  lines  analyzed.
Interestingly, while these two cell lines showed increased
Figure  5.  The  role  of  miR-29b  on  changes  in  expression  of
extracellular matrix genes induced by chronic oxidative stress. To
investigate  whether  miR-29b  under  chronic  oxidative  stress
conditions  could  affect  the  changes  in  expression  of  several
extracellular matrix (ECM) genes, three human trabecular meshwork
(HTM) cell lines were transfected with miR-29b mimic or control
mimic and incubated under oxidative stress conditions (40% O2) for
4 days. The changes in expression of COL1A2, COL5A1, COL3A1,
COL1A1, LAMC1, and SPARC compared to nonstressed controls
incubated at 5% oxygen and transfected with control mimic were
quantified by quantitative-PCR (Q- PCR). The figures represent the
logarithm  of  the  fold  change  in  gene  expression  between  cells
incubated at 40% oxygen transfected with either miR-29b mimic or
mimic control compared to control cultures (5% oxygen, mimic
control) for three individual cell lines. Bars represent standard error
from three different experiments. One asterisk means p≤0.05, and
two asterisks mean p≤0.01.
expression of several genes known to be validated targets of
miR-29b,  the  only  cell  line  where  miR-29b  was  not
downregulated (HTM3) showed no significant increase in the
expression of these genes. The upregulation of ECM genes
mediated by chronic oxidative stress in cells lines HTM1 and
HTM2 was inhibited by transfection with miR-29b. These
results suggest that downregulation of miR-29b could be a
mechanism that mediates some of the alterations in ECM
induced by chronic oxidative stress. The variability observed
in the levels of upregulation of each gene analyzed between
Figure 6. Effects of miR-29b on the cytotoxicity of human trabecular
meshwork  (HTM) cells. HTM cells transfected with miR-29b mimic
showed significantly lower levels of cytotoxicity measured by lactate
dehydrogenase release compared to cells transfected with control
mimic  when  incubated  at  both  40%  oxygen  and  5%  oxygen
conditions.  Bars  represent  standard  error  from  three  different
experiments. One asterisk means p≤0.05, and two asterisks mean
p≤0.01.
Molecular Vision 2009; 15:2488-2497 <http://www.molvis.org/molvis/v15/a266> © 2009 Molecular Vision
2495the  two  cell  lines  where  miR-29b  was  significantly
downregulated is likely to result from the influence of multiple
pathways  involved  in  the  regulation  of  the  ECM  under
oxidative stress conditions. However, our results suggest that
miR-29b may be an important regulatory component of this
process.
The  genes  selected  for  this  study  included  important
components  of  the  ECM,  such  as  COL1A2,  COL5A1,
COL3A1,  COL1A1,  LAMC,  and  the  matricellular  protein
SPARC that is known to promote ECM deposition [24,25].
Increased  expression  of  these  genes  could  potentially
influence  the  physiology  of  the  outflow  pathway  by
contributing to increased deposition of collagen and other
ECM  components  in  the  TM  [26-30].  Therefore,  the
variability observed in the effects of chronic oxidative stress
on  the  expression  of  miR-29b  could  be  relevant  to
understanding  individual  differences  in  susceptibility  to
pathophysiological alterations induced by chronic oxidative
stress in the outflow pathway.
In  addition  to  changes  in  the  expression  of  ECM
components,  our  results  also  showed  that  miR-29b  had  a
protective effect and decreased cell death. Such effect on cell
viability contrasts with the pro-apoptotic effects reported for
this miRNA in other cell types [16,31,32]. Members of the
miR-29 family, including miR-29b, have been demonstrated
to activate p53 by targeting p85α and CDC42 [31]. Because
of the known pro-apoptotic effects of p53, this function of
miR-29b would initially be expected to increase apoptosis
under chronic oxidative stress conditions. However, under
mild stress conditions, p53 is also known to exert antioxidant
and survival effects that are believed to be aimed at preventing
oxidative damage and ensuring the survival and repair of cells
encountering  only  low  levels  of  damage  [33].  Under  the
chronic oxidative conditions used in our model, cells might
suffer only a moderated level of damage, which would lead to
a  pro-survival  function  of  p53.  Furthermore,  transient
expression of miR-29a, which shares the same seed region of
miR-29b and also regulates p53 through targeting of p85α and
CDC42, did not result in increased apoptosis in osteoblasts
[31]. Thus, the pro-apoptotic effects reported for miR-29 may
be dependent on the cell type or the specific stress conditions
affecting the cells. It is also possible that additional targets of
miR-29b that have not been characterized may be involved in
the effects of miR-29b on cell survival in HTM cells. For
instance,  one  of  the  new  targets  identified  in  this  study,
NKRAS2,  is  a  negative  modulator  of  NFKB,  and  its
downregulation by miR-29b could potentially facilitate the
anti-apoptotic effects of NFKB.
In  conclusion,  miR-29b  negatively  modulated  the
expression of collagens and other key components of the ECM
in TM cells and decreased cytotoxicity in the presence of
chronic  oxidative  stress.  The  downregulation  of  miR-29b
observed in two cell lines could contribute to some of the
alterations in ECM metabolism and cell viability mediated by
chronic oxidative stress in HTM cells. The balance between
the activation of ECM production induced by oxidative stress
and the protective effects of miR-29b could be a relevant
factor in understanding how oxidative damage may lead to
increased deposition of ECM and decreased cellularity in the
outflow  pathway  and  contribute  to  the  elevation  of  intra-
ocular pressure in glaucoma. Strategies to increase miR-29
expression  in  TM  cells  may  be  beneficial  to  limit  ECM
deposition, prevent cell loss, and maintain normal levels of
aqueous humor outflow facility.
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